Corcept Therapeutics said on Monday its experimental drug in combination with chemotherapy helped delay progression of a type ...

AUTX-703, a novel and potent oral KAT2A and KAT2B protein degrader, inhibits growth and induces profound, persistent cell state differentiation in SCLC models ...

Treatment with VXM01, an investigational vaccine, plus Bavencio demonstrated both safety and tolerability in patients with ...

in treating the cancer, which is the most common oral epithelial malignancy in dogs. The drug substantially inhibited the growth of the tumors in mouse models and in dogs enrolled in a clinical trial.

Bad breath in pets is often dismissed as just an unfortunate quirk. But what if that odor is actually a warning sign of ...

DelveInsight’s, “Colorectal Cancer Pipeline Insight 2025” report provides comprehensive insights about 195+ companies and ...

Stay Hydrated: Drinking plenty of water helps wash away toxins and keeps your mouth clean, reducing the risk of infections and abnormal cell growth that lead to cancer. · Timely dental check-ups: ...

The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics.

CarePal Group, India’s integrated healthcare financing ecosystem released the State of Cancer Fundraising Report 2024, ...

Bayer’s BAYRY wholly owned and independently operated subsidiary, Vividion Therapeutics, Inc, announced that the first ...